Home / Atorvastatin and Amlodipine / Canada
CA ATC C10BX03 · updated 2 Nov 2026
Atorvastatin and Amlodipine shortage in Canada
Is there an Atorvastatin and Amlodipine shortage in Canada?
Yes. As of 2 Nov 2026, 5 Atorvastatin and Amlodipine products are reported short in Canada, the first since 1 Aug 2026. The company estimate for the return is 8 Dec 2026 (latest 12 Jan 2027). Main reason: increased demand.
Also short in Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MYLAN-AMLODIPINE/ATORVASTATIN (1x90BTL) | MYLAN PHARMACEUTICALS ULC | 1 Aug 2026 | 8 Dec 2026 | Increased demand Demand increase for the drug |
| CA | MYLAN-AMLODIPINE/ATORVASTATIN (90BT) | MYLAN PHARMACEUTICALS ULC | 5 Aug 2026 | 8 Dec 2026 | Increased demand Demand increase for the drug |
| CA | CADUET (1x90 BTL CA) anticipated | BGP PHARMA ULC | 8 Nov 2026 | 8 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-AMLODIPINE/ATORVASTATIN (1x90 BTL CA) anticipated | MYLAN PHARMACEUTICALS ULC | 17 Nov 2026 | 8 Dec 2026 | Increased demand Demand increase for the drug |
| CA | CADUET (1 x 90BTL) anticipated | BGP PHARMA ULC | 15 Dec 2026 | 12 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.